Evidence map›Paper›PMID 28217526›Full record

ArticleIndian journal of endocrinology and metabolism

The rule of two-thirds in diabetes epidemiology.

Sanjay Kalra, Banshi Saboo, Rakesh Sahay, Deepak Khandelwal, Vipin Talwar, A G Unnikrishnan

Open access · diamondAbstract read
In one paragraph

Article in Indian journal of endocrinology and metabolism. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
0.5field-weighted citation impact, top 27% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 10 citations in OpenAlex.

  1. Trial
  2. Article
  3. Applying the WHO global targets for diabetes mellitus.Nature reviews. Endocrinology · 2023
    Article
  4. Observational
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 4 institutions in 1 country.

Sanjay KalraDepartment of Endocrinology, Bharti Hospital, Karnal, Haryana, India.
Banshi SabooDepartment of Medicine, DiaCare, Ahmedabad, Gujarat, India.
Rakesh SahayDepartment of Endocrinology, Osmania Medical College, Hyderabad, Telangana, India.
Deepak KhandelwalDepartment of Endocrinology, Maharaja Agrasen Hospital, New Delhi, India.
Vipin TalwarDepartment of Endocrinology, Golden Hospital, Jalandhar City, Punjab, India.
A G UnnikrishnanDepartment of Endocrinology, CEO, Chellaram Diabetes Institute, Pune, Maharashtra, India.
Diabetes Care & Hormone Clinic · INBharti Hospital · INJaipur Golden Hospital · INOsmania Medical College · IN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

This communication hypothesises a rule of two thirds which seems to operate in Indian diabetes epidemiology. Two thirds of all persons with dysglycemia are prediabetic; two thirds of all persons with diabetes are diagnosed to have the condtion; and two thirds are diagnosed before the age of 50 years. Two thirds of people with diabetes have concomitant hypetension or dyslipidemia; two thirds do not get their HbA1c assessed; and two thirds of those who do, do not achiev target values. Yet, two thirds of people with diabetes report satisfactory psychosocial health and quality of life, and adherence to dietary therapy and medication. Only one thirds adhere to exercise and self monitoring advice, however. Two thirds of persons on oral glucose lowering drugs receive metformin; two thirds of those on insulin receive premixed insulin or twice daily isnuslin, and a similar proportion uses pens for delivery. Thus, the rule of two thirds, rather than of halves, operates in modern Indian diabetes practice.

Indexed as

EpidemiologyIndiaprediabetesrule of halvestype 2 diabetes

Identifiers

PMID28217526
PMCPMC5240070
OpenAlexW2561268192

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-SA
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.